Kingworld (01110.HK) announced its interim performance for the six months ending in June, with a revenue of 0.526 billion RMB, a year-on-year decrease of 4.9%. Net profit was recorded at 30.72 million yuan, a decline of 18.6%, with earnings per share of 5.2 fen. No interim dividend will be distributed.
《業績》金活醫藥(01110.HK)中期純利3,072萬人民幣跌18.6% 不派息
In terms of performance, China Jinhao Pharmaceuticals (01110.HK) reported a mid-year net profit of 30.72 million RMB, a decrease of 18.6% with no dividend payment.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated